There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Evidence supporting the addition of specific insulin regimens to oral therapy in patients
with type 2 diabetes mellitus is limited.
[1
]
Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University
of Oxford, Oxford, United Kingdom. rury.holman@dtu.ox.ac.uk